These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37019299)

  • 1. Dual role of nitric oxide in Alzheimer's disease.
    Azargoonjahromi A
    Nitric Oxide; 2023 May; 134-135():23-37. PubMed ID: 37019299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide.
    Balez R; Ooi L
    Oxid Med Cell Longev; 2016; 2016():3806157. PubMed ID: 26697132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Disease: A Contextual Link with Nitric Oxide Synthase.
    Dubey H; Gulati K; Ray A
    Curr Mol Med; 2020; 20(7):505-515. PubMed ID: 31782366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias.
    Togo T; Katsuse O; Iseki E
    Neurol Res; 2004 Jul; 26(5):563-6. PubMed ID: 15265275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type.
    Law A; Gauthier S; Quirion R
    Brain Res Brain Res Rev; 2001 Mar; 35(1):73-96. PubMed ID: 11245887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease.
    Fernández-Vizarra P; Fernández AP; Castro-Blanco S; Encinas JM; Serrano J; Bentura ML; Muñoz P; Martínez-Murillo R; Rodrigo J
    Neurobiol Dis; 2004 Mar; 15(2):287-305. PubMed ID: 15006699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β decreases nitric oxide production in cultured retinal neurons: a possible mechanism for synaptic dysfunction in Alzheimer's disease?
    Oliveira LT; Louzada PR; de Mello FG; Ferreira ST
    Neurochem Res; 2011 Jan; 36(1):163-9. PubMed ID: 20936504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease.
    de la Monte SM; Sohn YK; Etienne D; Kraft J; Wands JR
    Ann N Y Acad Sci; 2000 Apr; 903():61-71. PubMed ID: 10818490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alzheimer's disease as neurodegenerative disorder].
    Zabłocka A
    Postepy Hig Med Dosw (Online); 2006; 60():209-16. PubMed ID: 16641890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide impairs spatial learning and memory in a rat model of Alzheimer's disease via disturbance of glutamate response in the hippocampal dentate gyrus during spatial learning.
    Ren P; Xiao B; Wang LP; Li YS; Jin H; Jin QH
    Behav Brain Res; 2022 Mar; 422():113750. PubMed ID: 35033612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer's disease mice.
    Chakroborty S; Kim J; Schneider C; West AR; Stutzmann GE
    J Neurosci; 2015 Apr; 35(17):6893-902. PubMed ID: 25926464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalpol attenuates the neurotoxicity induced by beta-amyloid(1-42) in cortical neuron-glia cultures.
    Jiang B; Du J; Liu JH; Bao YM; An LJ
    Brain Res; 2008 Jan; 1188():139-47. PubMed ID: 18022141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation.
    Lüth HJ; Münch G; Arendt T
    Brain Res; 2002 Oct; 953(1-2):135-43. PubMed ID: 12384247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38 MAP kinase is involved in lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures.
    Jeohn GH; Cooper CL; Wilson B; Chang RC; Jang KJ; Kim HC; Liu B; Hong JS
    Ann N Y Acad Sci; 2002 May; 962():332-46. PubMed ID: 12076985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of neuronal nitric oxide synthase dimerization contributes to the development of Alzheimer's disease: Involvement of cyclin-dependent kinase 5-mediated phosphorylation of neuronal nitric oxide synthase at Ser(293).
    Kwon KJ; Park JH; Jo I; Song KH; Han JS; Park SH; Han SH; Cho DH
    Neurochem Int; 2016 Oct; 99():52-61. PubMed ID: 27296112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of NADPH-diaphorase staining, a marker of nitric oxide synthase activity, is altered in the perforant pathway terminal zone in Alzheimer's disease.
    Rebeck GW; Marzloff K; Hyman BT
    Neurosci Lett; 1993 Apr; 152(1-2):165-8. PubMed ID: 7685863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.
    Zhihui Q
    Future Med Chem; 2013 Aug; 5(12):1451-68. PubMed ID: 23919554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro.
    Haas J; Storch-Hagenlocher B; Biessmann A; Wildemann B
    Neurosci Lett; 2002 Apr; 322(2):121-5. PubMed ID: 11958858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide: target for therapeutic strategies in Alzheimer's disease.
    Fernandez AP; Pozo-Rodrigalvarez A; Serrano J; Martinez-Murillo R
    Curr Pharm Des; 2010; 16(25):2837-50. PubMed ID: 20698819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide in cerebellar development and function: focus on granule neurons.
    Contestabile A
    Cerebellum; 2012 Mar; 11(1):50-61. PubMed ID: 21104176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.